by Alice Wigington | May 26, 2026 | Uncategorized
EVolution Therapeutics is delighted to announce that we have joined the 2026 Accelerate@Babraham cohort. Supporting early-stage life science innovation Accelerate@Babraham is one of the UK’s leading life science accelerators. It helps early-stage companies strengthen...
by Alice Wigington | Apr 8, 2026 | Uncategorized
We’re excited to share that we’ve secured a place in Innovators Club Cohort VI! The Innovators Club is a 10-week accelerator programme run by the Science Entrepreneur Club (SEC). Over the coming months, we’ll strengthen our foundations through sessions on IP...
by Alice Wigington | Nov 11, 2025 | Uncategorized
EVolution Therapeutics has submitted its second patent application, marking another important milestone in the development of its RNA-enabled nanoparticle therapeutics platform. The new filing builds on the company’s growing intellectual property portfolio and...
by Alice Wigington | Oct 1, 2025 | Uncategorized
EVolution Therapeutics was last week invited to pitch at SPARK Global in Berlin, where co-founder and CTO, Professor Andrew Devitt, had the honour of presenting the company’s vision for transforming the treatment of chronic inflammatory disease through RNA-enabled...
